678 related articles for article (PubMed ID: 26254051)
1. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
Kowalski ML; Woessner K; Sanak M
J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
[TBL] [Abstract][Full Text] [Related]
2. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study.
Doña I; Blanca-López N; Torres MJ; Gómez F; Fernández J; Zambonino MA; Monteseirín FJ; Canto G; Blanca M; Cornejo-García JA
Allergy; 2014 Apr; 69(4):438-44. PubMed ID: 24372026
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions.
Saff RR; Banerji A
Allergy Asthma Proc; 2015; 36(1):34-9. PubMed ID: 25562554
[TBL] [Abstract][Full Text] [Related]
4. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions.
Zisa G; Riccobono F; Bommarito L; D'Antonio C; Calamari AM; Poppa M; Moschella MA; Di Pietrantonj C; Galimberti M
Allergy Asthma Proc; 2012; 33(5):421-6. PubMed ID: 23026184
[TBL] [Abstract][Full Text] [Related]
5. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance.
Blanca-Lopez N; J Torres M; Doña I; Campo P; Rondón C; Seoane Reula ME; Salas M; Canto G; Blanca M
Clin Exp Allergy; 2013 Jan; 43(1):85-91. PubMed ID: 23278883
[TBL] [Abstract][Full Text] [Related]
6. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.
Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
Am J Clin Dermatol; 2002; 3(9):599-607. PubMed ID: 12444802
[TBL] [Abstract][Full Text] [Related]
7. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
Doña I; Barrionuevo E; Salas M; Cornejo-García JA; Perkins JR; Bogas G; Prieto A; Torres MJ
Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
[TBL] [Abstract][Full Text] [Related]
8. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
[TBL] [Abstract][Full Text] [Related]
9. Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children.
Arikoglu T; Aslan G; Yildirim DD; Batmaz SB; Kuyucu S
Allergol Int; 2017 Jul; 66(3):418-424. PubMed ID: 27865769
[TBL] [Abstract][Full Text] [Related]
10. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.
Chaudhry T; Hissaria P; Wiese M; Heddle R; Kette F; Smith WB
Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353
[TBL] [Abstract][Full Text] [Related]
11. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
[TBL] [Abstract][Full Text] [Related]
12. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
Nosbaum A; Braire-Bourrel M; Dubost R; Faudel A; Parat S; Nicolas JF; Bérard F
Ann Allergy Asthma Immunol; 2013 Apr; 110(4):263-6. PubMed ID: 23535090
[TBL] [Abstract][Full Text] [Related]
13. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
Asero R
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
[TBL] [Abstract][Full Text] [Related]
15. Aspirin desensitization in a patient with NSAID-induced delayed angioedema.
Rijo Y; Canabal J; Fiandor A; Bobolea I; Quirce S; Cabañas R
J Investig Allergol Clin Immunol; 2015; 25(2):156-8. PubMed ID: 25997319
[No Abstract] [Full Text] [Related]
16. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity.
Knowles SR; Drucker AM; Weber EA; Shear NH
Ann Pharmacother; 2007 Jul; 41(7):1191-200. PubMed ID: 17609236
[TBL] [Abstract][Full Text] [Related]
17. Avoidance of nonsteroidal anti-inflammatory drugs after negative provocation tests in urticaria/angioedema reactions: Real-world experience.
Bommarito L; Zisa G; Riccobono F; Villa E; D'Antonio C; Calamari AM; Poppa M; Moschella A; Di Pietrantonj C; Galimberti M
Allergy Asthma Proc; 2014; 35(4):303-6. PubMed ID: 24992549
[TBL] [Abstract][Full Text] [Related]
18. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria.
Doña I; Jurado-Escobar R; Perkins JR; Ayuso P; Plaza-Serón MC; Pérez-Sánchez N; Campo P; Bogas-Herrera G; Bartra J; Torres MJ; Sanak M; Cornejo-García JA
Allergy; 2019 Jun; 74(6):1135-1144. PubMed ID: 30667070
[TBL] [Abstract][Full Text] [Related]
19. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
[TBL] [Abstract][Full Text] [Related]
20. Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified.
Pérez-Alzate D; Cornejo-García JA; Pérez-Sánchez N; Andreu I; García-Moral A; Agúndez JA; Bartra J; Doña I; Torres MJ; Blanca M; Blanca-López N; Canto G
J Investig Allergol Clin Immunol; 2017; 27(1):32-39. PubMed ID: 28211343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
